Health Discovery (HDVY) Stock Price, News & Analysis

Company Overview

Health Discovery (OTCMKTS:HDVY) is a U.S.-based healthcare development company focused on acquiring, advancing and commercializing innovative medical and biotechnology products. Through a combination of in‐house research and strategic partnerships, the company identifies early‐stage assets in areas such as oncology diagnostics, digital health monitoring and gene therapy. Health Discovery’s core strategy involves securing exclusive licensing agreements and overseeing preclinical and clinical programs to guide promising technologies through regulatory milestones.

Since its founding in 2010, Health Discovery has pursued a disciplined acquisition model, targeting companies and intellectual property that align with its long-term vision for preventive and personalized medicine. The company maintains research and development operations in Colorado and collaborates with academic institutions and contract research organizations across North America and Europe. Its current pipeline includes a non-invasive, saliva-based test for early cancer detection, a remote patient monitoring platform for chronic disease management and a proprietary vector system for targeted gene delivery.

Under the leadership of CEO John M. Plakas and CFO Kathy J. Pierson, Health Discovery has strengthened its governance and operational infrastructure to support clinical development and potential commercialization activities. The executive team combines expertise in regulatory affairs, clinical operations and market access, positioning the company to navigate complex approval pathways. With a focus on unmet medical needs and emerging technologies, Health Discovery aims to leverage its portfolio approach to generate value for stakeholders as it advances each program toward market readiness.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: $40 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

HDVY Stock Analysis - Frequently Asked Questions

How were Health Discovery's earnings last quarter?

Health Discovery Corp. (OTCMKTS:HDVY) posted its quarterly earnings data on Tuesday, June, 30th. The company reported $0.00 earnings per share (EPS) for the quarter.

How do I buy shares of Health Discovery?

Shares of HDVY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Health Discovery own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Health Discovery investors own include Ford Motor (F), Ericsson (ERIC), Hydrofarm Holdings Group (HYFM), Intel (INTC), JD.com (JD), Lucid Group (LCID) and Uranium Energy (UEC).

Company Calendar

• Last Earnings: 6/30/2020
• Today: 7/12/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED - BIOMED/GENE
• Sub-Industry: Trading
• Current Symbol: OTCMKTS:HDVY
• CIK: 1141788
• Web: www.healthdiscoverycorp.com
• Phone: (404) 566-4865
• Fax: N/A
• Employees: 3
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 420,330,000
• Free Float: 284,986,000
• Market Cap: $40 thousand
• Optionable: Not Optionable
• Beta: 1.24